337
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats

, , ORCID Icon, , , , , , & show all
Pages 2199-2206 | Published online: 04 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Johannes Boyer, Martin Hoenigl & Lisa Kriegl. (2024) Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?. Expert Review of Clinical Pharmacology 17:4, pages 309-321.
Read now
Shan Zhou, Fang-Ling Zhao, Shuang-Hu Wang, Yi-Ran Wang, Yun Hong, Quan Zhou, Pei-Wu Geng, Qing-Feng Luo, Jian-Ping Cai & Da-Peng Dai. (2023) Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo. Pharmaceutical Biology 61:1, pages 356-361.
Read now
Yun Hong, Da-Peng Dai, Jian-Ping Cai, Shuang-Hu Wang, Yi-Ran Wang, Fang-Ling Zhao, Shan Zhou, Quan Zhou, Pei-Wu Geng, Yun-Fang Zhou, Xue Xu, Ji-Hua Shi & Qing-Feng Luo. (2022) Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo. Drug Design, Development and Therapy 16, pages 1779-1789.
Read now
Feifei Chen, Hui Jiang, Jia Xu, Shuanghu Wang, Deru Meng, Peiwu Geng, Dapeng Dai, Quan Zhou & Yunfang Zhou. (2020) In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine. Drug Design, Development and Therapy 14, pages 4815-4824.
Read now

Articles from other publishers (7)

Austin Royster, Songyang Ren, Yutian Ma, Melissa Pintado, Eunice Kahng, Sean Rowan, Sheema Mir & Mohammad Mir. (2023) SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery. Microbiology Spectrum 11:3.
Crossref
Nazleen Mohseni, Austin Royster, Songyang Ren, Yutian Ma, Melissa Pintado, Mohammad Mir & Sheema Mir. (2023) A novel compound targets the feline infectious peritonitis virus nucleocapsid protein and inhibits viral replication in cell culture. Journal of Biological Chemistry 299:3, pages 102976.
Crossref
Yuhao Fu, Ying Li, Yinling Ma, Xueru He, Xuejiao Xun, Yanjun Cui, Liju Fan & Zhanjun Dong. (2022) Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC–MS/MS. Biomedical Chromatography 37:1.
Crossref
Yoshio Takesue, Yuki Hanai, Kazutaka Oda, Yukihiro Hamada, Takashi Ueda, Toshihiko Mayumi, Kazuaki Matsumoto, Satoshi Fujii, Yoshiko Takahashi, Yoshitsugu Miyazaki & Toshimi Kimura. (2022) Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clinical Therapeutics 44:12, pages 1604-1623.
Crossref
Yiran Wang, Jihua Shi, Dapeng Dai, Jianping Cai, Shuanghu Wang, Yun Hong, Shan Zhou, Fangling Zhao, Quan Zhou, Peiwu Geng, Yunfang Zhou, Xue Xu & Qingfeng Luo. (2022) Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo. Frontiers in Pharmacology 13.
Crossref
Yichang Zhao, Jingjing Hou, Yiwen Xiao, Feng Wang, Bikui Zhang, Min Zhang, Yongfang Jiang, Jiakai Li, Guozhong Gong, Daxiong Xiang & Miao Yan. (2021) Predictors of Voriconazole Trough Concentrations in Patients with Child–Pugh Class C Cirrhosis: A Prospective Study. Antibiotics 10:9, pages 1130.
Crossref
Ji-Sang Lee, Hyo-Sung Kim, Yong-Seob Jung, Hyeon-Gyeom Choi & So-Hee Kim. (2021) Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats. Pharmaceutics 13:5, pages 740.
Crossref